Mycofoli 700 Tablet contains Mycophenolate Sodium 700 mg, a high-potency immunosuppressant widely used in organ transplant medicine to prevent graft rejection.
This tablet works by inhibiting inosine monophosphate dehydrogenase (IMPDH), suppressing T- and B-lymphocyte proliferation and reducing immune-mediated damage to transplanted organs. It is ideal for patients requiring higher-dose immunosuppression in renal, cardiac, or hepatic transplant regimens, under strict medical supervision.
Clinically, Mycofoli 700 Tablet is used in combination with calcineurin inhibitors and corticosteroids to maintain graft survival, minimize rejection episodes, and ensure post-transplant stability.
The tablet ensures accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, transplant centers, specialty pharmacies, and healthcare providers managing intensive post-transplant immunosuppressive therapy.